Molecular and Pathological Profiling of Corresponding Treatment-Naïve and Neoadjuvant Pazopanib-Treated High-Risk Soft Tissue Sarcoma Samples of the GISG-04/NOPASS Study

SIMPLE SUMMARY: Patients with malignant soft tissue tumors, called soft tissue sarcoma (STS), show alterations in their deoxyribonucleic acid (DNA). Pathologists use these alterations for classification of STS and as drug-related biomarkers. Some drugs show better effectiveness in association with c...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaiser, Timo, Sauer, Christian, Marx, Alexander, Jakob, Jens, Kasper, Bernd, Hohenberger, Peter, Hirsch, Daniela, Ronellenfitsch, Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301157/
https://www.ncbi.nlm.nih.gov/pubmed/34356494
http://dx.doi.org/10.3390/biology10070639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301157/
https://www.ncbi.nlm.nih.gov/pubmed/34356494
http://dx.doi.org/10.3390/biology10070639

Ejemplares similares